Orbimed Advisors LLC Assembly Biosciences, Inc. Transaction History

Orbimed Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$9.83 - $14.82 $5.15 Million - $7.76 Million	-523,600 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$12.9 - $20.8 $6.1 Million - $9.83 Million	-472,523 Reduced 47.44%	523,600 $7.06 Million
Q4 2018 Feb 14, 2019	SELL	$19.05 - $36.45 $4.52 Million - $8.65 Million	-237,248 Reduced 19.24%	996,123 $22.5 Million
Q3 2018 Nov 14, 2018	BUY	$34.41 - $44.23 $17.6 Million - $22.7 Million	512,205 Added 71.02%	1,233,371 $45.8 Million
Q1 2018 May 15, 2018	SELL	$41.7 - $64.16 $19.9 Million - $30.6 Million	-476,860 Reduced 39.8%	721,166 $35.4 Million
Q4 2017 Feb 14, 2018	BUY	$28.58 - $49.91 $12.9 Million - $22.5 Million	450,000 Added 60.16%	1,198,026 $54.2 Million
Q3 2017 Nov 14, 2017	BUY	$23.08 - $34.92 $17.3 Million - $26.1 Million	748,026	748,026 $26.1 Million

16.3K

Ticker ASMB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,436,900
Market Cap $766M
Description
Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus (HBV) infection in the United States. The company's lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also deve...

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Orbimed Advisors LLC with notifications on news.